Shelter Pharma Limited has announced a board meeting approving a fundraise of up to INR 38.46 Cr through the issue of 91.02 lakh Convertible Equity Warrants at INR 42.25 each to both promoter and non-promoter investors via preferential and private placement. Each warrant can be converted into one equity share within 18 months. An Extraordinary General Meeting is scheduled to approve the issue. The company appointed M/s Murtuza Mandorwala & Associates as scrutinizer for fair voting processes. The trading window will reopen shortly, signaling readiness for capital infusion to support business growth and operations.